James Coley
Hematology & Oncology · Wilmington, NCNPI 1437610698
Payments from drug & device makers
Across 62 payments — averaging $38.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$522
- Incyte Corporation$273
- Merck$222
- Gilead$216
- Beigene USA, Inc.$205
- Novartis$140
- plus $789 from 16 others
What the payments were for
- Food & beverage$2,25195%
- Education$1165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $522 |
| Incyte Corporation | 3 | $273 |
| Merck | 6 | $222 |
| Gilead | 2 | $216 |
| Beigene USA, Inc. | 5 | $205 |
| Novartis | 3 | $140 |
| E.r. Squibb & Sons, L.L.C. | 4 | $129 |
| Stemline Therapeutics Inc. | 1 | $123 |
| Astellas Pharma US Inc | 2 | $115 |
| Johnson & Johnson | 4 | $69 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Pfizer | 4 | $55 |
| Beone Medicines USA, Inc. | 2 | $43 |
| Genentech, Inc. | 1 | $36 |
| Legend Biotech USA Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Exelixis Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Adaptive Biotechnologies Corporation | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Tersera Therapeutics LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,367 in reported general payments places this provider in the 35th percentile of 358 hematology & oncology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 33 | $537 |
| Anastrozole | 22 | $276 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Wilmington
- John PowderlyHuntersville$21.2M
- Kimberly BlackwellDurham$13.2M
- Joshua ZeidnerChapel Hill$11.2M
- Shelbi AtrashCharlotte$9.5M
- Matthew WieduwiltWinston Salem$9.5M
- Danielle BranderDurham$8.6M
- Jared WeissChapel Hill$7.3M
- Michael MorseDurham$6M
- Autumn McReeChapel Hill$5.5M
- Darla LilesGreenville$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.